The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 trial of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors.
 
Jacob Stephen Thomas
Consulting or Advisory Role - Array BioPharma
Travel, Accommodations, Expenses - eFFECTOR Therapeutics; Pfizer
 
Diane Habib
No Relationships to Disclose
 
Diana L. Hanna
Consulting or Advisory Role - Boehringer Ingelheim
 
Irene Kang
Honoraria - Bristol Myer Squibb; Puma Biotechnology
Speakers' Bureau - Puma Biotechnology
 
Syma Iqbal
Honoraria - AstraZeneca; Celgene; Eisai
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - Celgene
 
Jorge J. Nieva
Stock and Other Ownership Interests - Cansera; Epic Sciences; Indee P/L; Quantgene
Consulting or Advisory Role - AstraZeneca; Fujirebio Diagnostics; Naveris
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Patent Pending - movement and unexpected healthcare encounters
 
Denice Tsao-Wei
No Relationships to Disclose
 
Francisco Acosta
No Relationships to Disclose
 
Ming Hsieh
Employment - Fulgent Pharma
Leadership - Fulgent Pharma
Stock and Other Ownership Interests - Fulgent Pharma
Patents, Royalties, Other Intellectual Property - Fulgent Pharma
Travel, Accommodations, Expenses - Fulgent Pharma
 
Yilong Zhang
Employment - Fulgent Pharma
Leadership - Fulgent Pharma
Stock and Other Ownership Interests - Fulgent Pharma
Patents, Royalties, Other Intellectual Property - Fulgent Pharma
Travel, Accommodations, Expenses - Fulgent Pharma
 
Anthony B. El-Khoueiry
Honoraria - ABL bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - ABL Bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Merck